Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
99.30    2.40 (2.48%)
Bid:
96.90
Ask:
98.10
Spread: 1.20 (1.238%)
Market Cap: £589.34m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Directorate change

Today 07:00

RNS Number : 5454I
Syncona Limited
17 June 2026
 

Syncona Limited

 

Norman Crighton Appointed as a Non-Executive Director

 

17 June 2026

 

Syncona Ltd, (the "Company"), a leading life science investor, announces the appointment of Norman Crighton as an independent Non-Executive Director, with effect from 1 July 2026.

 

Norman Crighton has over 35 years of experience in the investment company industry, spanning investment banking, fund management, and board-level governance. As head of a multinational investment banking department, he advised on the structuring and restructuring of closed-end funds with a focus on sustainable NAV-relative pricing and discount management. As a fund manager, he ran portfolios of investment companies on both a hedged and unhedged basis.

 

Since 2011, Norman has served as a non-executive director on the boards of nine listed investment companies, being chair of six of them, and one operating company, bringing particular expertise in IPO structuring, corporate governance, and shareholder value creation. He has a strong track record of working with boards and shareholders to narrow persistent discounts and align fund structures with investor expectations.

 

Norman holds a BA (Hons) in Applied Economics and an MA in Finance and Investment. He currently serves as Chair of RM Infrastructure Income and AVI Japan Opportunity Trust and sits as a Non-Executive Director of Gore Street Energy Storage Fund. Norman previously served as Chair of Harmony Energy Income Trust plc between 2021 and 2025.

 

On appointment, Norman will join the Company's Audit Committee, Remuneration Committee and Nomination and Governance Committee.

 

Melanie Gee, Chair of Syncona Ltd, said: "We are delighted to welcome Norman to the Syncona Board. He brings extensive experience of the investment company sector and has a strong track record of working with Boards to deliver shareholder returns. His expertise will be particularly important to the Company as it focuses on the delivery of our recently approved new Investment Policy and the return of a minimum of £250 million of proceeds to shareholders in a timely manner."

 

Norman Crighton said: "I am pleased to be joining the Syncona Board and working with the SIML team to deliver on shareholders' near-term priorities. I am looking forward to applying my experience in supporting the Company as it seeks to address the discount at which its shares are trading, through the delivery of its recently approved Investment Policy."

 

No further details are required to be disclosed under UKLR 6.4.8R.

 

Enquiries

 

Syncona Ltd

 

Annabel Clark

Tel: +44 (0) 20 3981 7912

 

FTI Consulting

 

Ben Atwell / Natalie Garland-Collins / Tim Stamper

Tel: +44 (0) 20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFIFIMEMSEDM
Date   Source Headline
17th Jun 20267:00 amRNSDirectorate change
19th May 20263:00 pmRNSHolding(s) in Company
18th May 20263:30 pmRNSHolding(s) in Company
7th May 20266:25 pmRNSHolding(s) in Company
16th Mar 20262:16 pmRNSHolding(s) in Company
16th Mar 20262:16 pmRNSHolding(s) in Company
3rd Mar 202611:00 amRNSResults of General Meeting and Board Changes
3rd Mar 20269:30 amRNSQuell Clinical Updates
12th Feb 202612:00 pmRNSPublication of Circular
5th Feb 20267:00 amRNSThird Quarter Update
8th Jan 202612:01 pmRNSBeacon raises $75m in oversubscribed Series C
28th Nov 20256:00 pmRNSTotal Voting Rights
17th Nov 20257:00 amRNSIssue of shares pursuant to incentive scheme
13th Nov 20257:00 amRNSHalf-year Report
12th Nov 20254:30 pmRNSAutolus reports Q3 2025 Financial Results
21st Oct 20257:00 amRNSStrategy update
18th Sep 20255:30 pmRNSHolding(s) in Company
4th Sep 20251:05 pmRNSBeacon positive interim data for Phase 2 studies
13th Aug 20254:30 pmRNSAutolus reports Q2 2025 Financial Results
7th Aug 20257:00 amRNSFirst Quarter Update
5th Aug 20252:07 pmRNSDirectorate Change
5th Aug 20252:06 pmRNSResult of AGM
2nd Jul 20257:00 amRNSNotice of AGM
1st Jul 20259:36 amRNSTotal Voting Rights
19th Jun 20257:00 amRNSStrategy Update
19th Jun 20257:00 amRNSFinal Results
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20251:00 pmRNSAutolus Data Updates
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20254:32 pmRNSHolding(s) in Company
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202511:35 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.